Table 2.
Sample | Parameter | Control | CM (days 6–7) | NCM (days 6–7) | NCM (days 14–22) |
---|---|---|---|---|---|
Brain | Lactate (μmol/g wet wt) | 1.50 ± 0.06 | 6.38 ± 0.44* | 1.50 ± 0.02 | 1.71 ± 0.06 |
Pyruvate (μmol/g wet wt) | 0.39 ± 0.02 | 0.44 ± 0.02 | 0.40 ± 0.01 | 0.66 ± 0.03* | |
Lactate:pyruvate ratio | 3.8 ± 0.1 | 14.2 ± 0.3* | 3.7 ± 0.1 | 2.6 ± 0.1* | |
Blood | Lactate (μmol/mL) | 5.64 ± 0.08 | 3.74 ± 0.19* | 4.63 ± 0.17 | 10.06 ± 0.21* |
Pyruvate (μmol/mL) | 0.18 ± 0.01 | 0.16 ± 0.01 | 0.14 ± 0.05 | 0.75 ± 0.06* | |
Lactate:pyruvate ratio | 31.8 ± 1.1 | 23.6 ± 0.6* | 32.4 ± 0.2 | 12.5 ± 0.5* | |
Parasitemia | 0 | 13.2 ± 2.2* | 10.1 ± 0.6* | 66.2 ± 1.9* |
Values are mean ± SEM (n = 5).
*Indicates P < 0.01 (Mann-Whitney U test) compared to uninfected control values.